Mangoceuticals (MGRX) Gross Profit (2023 - 2026)
Mangoceuticals recorded quarterly Gross Profit of $29001.0 in Q1 2026, down 38.91% quarter-over-quarter from $47475.0 in Q4 2025, and down 53.27% year-over-year from $62064.0 in Q1 2025.
Mangoceuticals' Gross Profit history runs 4 years deep, the most recent figure standing at $29001.0 for Q1 2026.
- In Q1 2026, Gross Profit fell 53.27% year-over-year to $29001.0; the TTM figure through Mar 2026 stood at $217323.0 (down 26.24% YoY), while the FY2025 annual figure was $250386.0, down 34.1% from the prior year.
- Gross Profit came in at $29001.0 for Q1 2026 at Mangoceuticals, down from $47475.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $147398.0 in Q1 2024 to a low of $29001.0 in Q1 2026.
- A 4-year average of $83911.7 and a median of $80103.0 in 2024 frame the typical range for Gross Profit.
- Across the five-year window, Gross Profit surged 157.69% in 2024 and slumped 57.89% in 2025, its largest moves.
- Mangoceuticals' Gross Profit stood at $142583.0 in 2023, then slumped by 43.82% to $80103.0 in 2024, then sank by 40.73% to $47475.0 in 2025, then plunged by 38.91% to $29001.0 in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $29001.0, $47475.0, and $50899.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,001.00 |
| Mar 31, 2026 | 29,001.00 |
| Dec 31, 2025 | 47,475.00 |
| Dec 31, 2025 | 47,475.00 |
| Sep 30, 2025 | 50,899.00 |
| Sep 30, 2025 | 50,899.00 |
| Jun 30, 2025 | 89,948.00 |
| Jun 30, 2025 | 89,948.00 |
| Mar 31, 2025 | 62,064.00 |
| Mar 31, 2025 | 62,064.00 |
| Dec 31, 2024 | 80,103.00 |
| Dec 31, 2024 | 80,103.00 |
| Sep 30, 2024 | 82,671.00 |
| Sep 30, 2024 | 82,671.00 |
| Jun 30, 2024 | 69,792.00 |
| Jun 30, 2024 | 69,792.00 |
| Mar 31, 2024 | 147,398.00 |
| Mar 31, 2024 | 147,398.00 |
| Dec 31, 2023 | 142,583.00 |
| Dec 31, 2023 | 142,583.00 |
| Sep 30, 2023 | 144,589.00 |
| Sep 30, 2023 | 144,589.00 |
| Jun 30, 2023 | 87,130.00 |
| Jun 30, 2023 | 87,130.00 |
| Mar 31, 2023 | 57,199.00 |
| Mar 31, 2023 | 57,199.00 |